Fibrate treatment of eEOCs in murine AKI

scientific article published on 16 January 2014

Fibrate treatment of eEOCs in murine AKI is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1020304639
P356DOI10.1007/S40620-013-0027-Y
P698PubMed publication ID24430761

P2093author name stringGerhard Anton Müller
Daniel Patschan
Susann Patschan
Elvira Henze
Katrin Schwarze
Roman Scheidemann
P2860cites workDysfunctional endothelial progenitor cells in chronic kidney diseaseQ84068669
Effects of fenofibrate, a PPAR-α ligand, on the haemodynamics of glycerol-induced renal failure in ratsQ84717456
Angiopoietin-2 modulates eEOC-mediated renoprotection in AKI in a dose-dependent mannerQ86333861
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerQ21328702
Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunityQ27013011
The mechanisms of action of PPARsQ28216953
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptorsQ28276138
Isolation of putative progenitor endothelial cells for angiogenesisQ28302884
Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ça ira.Q33234298
Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidneyQ33333234
Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell culturesQ33385959
Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survivalQ35074059
Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt HypertensionQ35608633
PPAR-α Agonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5'-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells.Q35608768
Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesisQ35651689
Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused MiceQ36119361
Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cellsQ36318813
The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process?Q37374031
Cord blood-derived early outgrowth endothelial progenitor cellsQ37677859
Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?Q37979621
PPAR agonists for the treatment of cardiovascular disease in patients with diabetesQ37996437
Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injuryQ39582724
Activation of Epac stimulates integrin-dependent homing of progenitor cellsQ40046169
Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competenceQ41916873
Regulation of cerebrovascular endothelial peroxisome proliferator activator receptor alpha expression and nitric oxide production by clofibrateQ42473259
Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injuryQ42621335
Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARα deterioration.Q42749724
Involvement of PPARα and PPARγ in apoptosis and proliferation of human hepatocarcinoma HepG2 cells.Q42878662
Human cord blood CD133+ cells exacerbate ischemic acute kidney injury in miceQ44579820
Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formationQ44796931
Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism.Q46939329
High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.Q53206633
Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells.Q53561437
Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitorsQ62590334
Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factorsQ73075799
Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioningQ82554662
Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysisQ83306839
The hormone melatonin stimulates renoprotective effects of "early outgrowth" endothelial progenitor cells in acute ischemic kidney injuryQ83493394
P433issue1
P304page(s)37-44
P577publication date2014-01-16
P1433published inJournal of NephrologyQ15765408
P1476titleFibrate treatment of eEOCs in murine AKI
P478volume27

Reverse relations

Q41048729Endothelial autophagy and Endothelial-to-Mesenchymal Transition (EndoMT) in eEPC treatment of ischemic AKI.cites workP2860

Search more.